Widely used:Recently Viewed
Clear All
Bidding Date
25-Apr-2023 to
27-Apr-2023
Issue Size
₹4326.36 Cr
Price Band
₹1026 to ₹1080
Allotment date
03-May-2023
Listing date
09-May-2023
Lot size
13
No. of shares
4,00,58,844
Fresh issue/OFS
-- / ₹4326.36 Cr
No data found. Please visit the stock details page to know more about the company.
Read our in-depth analysis of the Mankind Pharma Ltd. IPO Here 
Category
Status
QIBs
49.2x
NIIs
3.8x
Retail
0.9x
Others
--
Total
15.3x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Aakaar Medical Technologies | 68 - 72 | 20-Jun-2025 to 24-Jun-2025 |
| Mayasheel Ventures | 44 - 47 | 20-Jun-2025 to 24-Jun-2025 |
| Safe Enterprises Retail Fixtures | 131 - 138 | 20-Jun-2025 to 24-Jun-2025 |
| Ace Alpha Tech | 101 - 107 | 26-Jun-2025 to 30-Jun-2025 |
The issue size of Mankind Pharma Ltd. is ₹4,326.36 Cr.
Mankind Pharma Ltd. falls into Pharmaceuticals industry.
The Mankind Pharma Ltd. IPO will be listed on NSE.
The open and close dates for the Mankind Pharma Ltd. are 25-Apr-2023 & 27-Apr-2023.
The price band for the Mankind Pharma Ltd. ipo is ₹1026 to ₹1080
The listing date of Mankind Pharma Ltd. IPO is 09-May-2023.
The purpose of this IPO is to enable the existing shareholders to sell their stake.
Mankind Pharma Ltd. total subscription ratio is 15.3X.
Key financial of the Mankind Pharma Ltd. are:
| Mankind Pharma Ltd. | FY-23 | FY-22 | FY-21 | FY-20 |
|---|---|---|---|---|
| Revenue (₹ Cr) | 8749.43 | 7781.56 | 6214.43 | 5871.87 |
| EBIT (₹ Cr) | 1576.01 | 1823.93 | 1530.14 | 1345.65 |
| Proft after Tax (₹ Cr) | 1309.68 | 1452.96 | 1293.03 | 1056.14 |
| Debt (₹ Cr) | 162.64 | 868.03 | 234.53 | 128.05 |
| Net Worth (₹ Cr) | 7435.22 | 6155.23 | 4722 | 3485.31 |
| RoE (%) | 17.61 | 23.61 | 27.38 | 30.3 |
